Tranexamic acid is a synthetic derivative of [lysine] used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to [aminocaproic acid] but is approximately 10-fold more potent.[L31883] It was first patented in 1957[A230108] and received its initial US approval in 1986.[L31858]
Synonyms
trans-4-aminomethylcyclohexane-1-carboxylic acid
trans-Tranexamic acid
Acide tranéxamique
Trans AMCHA
trans-Amcha
Tranexamic acid
Tranexamsaeure
Tranexmic acid
ácido tranexámico
Acidum tranexamicum
Tranhexamic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
Brand Names
SKINMD LABORATORIES ReviTox blue
Skinmd Laboratories Pure Whitenol Intensive
Pure Whitenol Serum
Lysteda
Tranexamic acid
Cyklokapron
Skinmd Laboratories Pure Whitenol Serum
Gd-tranexamic Acid
Tranexamic Acid In Sodium Chloride
Tranexamic Acid
Tranexamic Acid Injection
Cyklokapron 500 mg
Mar-tranexamic Acid
Tranexamic Acid Injection, USP
Erfa-tranexamic
Tranexamic Acid Tablets
Cyklokapron 100 mg/ml
Tranexamic Acid Injection BP
Indication
Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema,[L31883] cyclic heavy menstrual bleeding in premenopausal females,[L31858] and other instances of significant bleeding in the context of hyperfibrinolysis.[L31883] Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleeding following tooth extraction.[L31853]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682